Concepedia

Belén Atienza‐Mateo

BA

39

Publications

1.2K

Citations

19

H-Index

2018

Active since

Affiliations

Instituto de Investigación Marqués de Valdecilla(Current)

Universidad de Cantabria

Marqués de Valdecilla University Hospital

University of the Witwatersrand

Hospital de Basurto

Belén Atienza‐Mateo is an author at Instituto de Investigación Marqués de Valdecilla specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

2018–2025

39

Publications

39

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida et al. · American Journal of Ophthalmology · 2019 · 111 citations · Full text

, , +5

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río et al. · Arthritis & Rheumatology · 2019 · 105 citations · Full text

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

Belén Atienza‐Mateo, V. Calvo-Río, E. Beltrán et al. · Lara D. Veeken · 2018 · 104 citations

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

L. Sánchez-Bilbao, D. Martínez-López, Marcelino Revenga et al. · Journal of Clinical Medicine · 2020 · 81 citations · Full text

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

J. L. Martín-Varillas, V. Calvo-Río, E. Beltrán et al. · Ophthalmology · 2018 · 65 citations · Full text

, , +6

Rows per page

1–5 of 39